Anne Lecocq
Senior Vice President and General Manager, Research & Development
Anne Lecocq is a seasoned life sciences executive with over 20 years of experience. She began her career in the pharmaceutical and generics industries, specializing in regulatory compliance and chemistry, manufacturing and controls (CMC), before joining Clarivate in 2008.
At Clarivate, Anne has held multiple leadership roles overseeing data and content strategy for Cortellis solutions spanning drug discovery, clinical trials, competitive intelligence, safety, and regulatory intelligence. In her current role as General Manager of the R&D Business, she drives product innovation and strategic growth for the Cortellis product suite, enabling biopharma organizations to accelerate the delivery of life-changing therapies to patients through actionable intelligence and advanced analytics.
Anne holds dual master’s degrees in Biotechnology & Chemistry and Regulatory Affairs. Based in Paris, France, she is passionate about leveraging her multidisciplinary expertise to advance global R&D efficiency through transformative intelligence.
Latest news
Clarivate to Present at the Goldman Sachs Communacopia + Technology Conference on September 11
London, UK – September 4, 2025, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will…
16th Annual Clarivate Pharmavision India Conference to Address Market Shifts, Innovation and Global Access
2025 event to explore how Indian pharmaceutical companies can capture new growth in generics and biosimilars while navigating competition and regulatory complexities London, U.K. September 1, 2025: Clarivate Plc (NYSE:CLVT),…